Elizabeth C. Cushman serves as Executive at ABBOTT LABORATORIES, where they oversee executive responsibilities. Since joining the company, Elizabeth C. Cushman has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 27, 2025 involved receiving (via award) 3,790 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 27, 2025 | ABT | $0 | Award | 3,790 | $N/A | Discretionary |
Elizabeth C. Cushman currently holds 25,226 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth C. Cushman has been a net neutral trader of ABT stock. They have purchased $0 and sold $0 worth of shares.
Elizabeth C. Cushman's most recent insider trade was on Jun 27, 2025, when they sold 3,790 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted